TABLE 1 Asia Pacific Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 3 Asia Pacific Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 4 Asia Pacific Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 5 Asia Pacific Aflibercept Market by Country, 2019 - 2022, USD Million
TABLE 6 Asia Pacific Aflibercept Market by Country, 2023 - 2030, USD Million
TABLE 7 Asia Pacific Ranibizumab Market by Country, 2019 - 2022, USD Million
TABLE 8 Asia Pacific Ranibizumab Market by Country, 2023 - 2030, USD Million
TABLE 9 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 10 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 11 Asia Pacific Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 12 Asia Pacific Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 13 Asia Pacific Wet Market by Country, 2019 - 2022, USD Million
TABLE 14 Asia Pacific Wet Market by Country, 2023 - 2030, USD Million
TABLE 15 Asia Pacific Dry Market by Country, 2019 - 2022, USD Million
TABLE 16 Asia Pacific Dry Market by Country, 2023 - 2030, USD Million
TABLE 17 Asia Pacific Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 18 Asia Pacific Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 19 Asia Pacific Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 20 Asia Pacific Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 21 Asia Pacific Retail Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 22 Asia Pacific Retail Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 23 Asia Pacific Online Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 24 Asia Pacific Online Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 25 Asia Pacific Age Related Macular Degeneration (AMD) Market by Country, 2019 - 2022, USD Million
TABLE 26 Asia Pacific Age Related Macular Degeneration (AMD) Market by Country, 2023 - 2030, USD Million
TABLE 27 China Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 28 China Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 29 China Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 30 China Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 31 China Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 32 China Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 33 China Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 34 China Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 35 Japan Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 36 Japan Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 37 Japan Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 38 Japan Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 39 Japan Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 40 Japan Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 41 Japan Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 42 Japan Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 43 India Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 44 India Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 45 India Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 46 India Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 47 India Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 48 India Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 49 India Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 50 India Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 51 South Korea Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 52 South Korea Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 53 South Korea Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 54 South Korea Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 55 South Korea Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 56 South Korea Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 57 South Korea Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 58 South Korea Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 59 Singapore Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 60 Singapore Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 61 Singapore Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 62 Singapore Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 63 Singapore Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 64 Singapore Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 65 Singapore Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 66 Singapore Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 67 Malaysia Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 68 Malaysia Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 69 Malaysia Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 70 Malaysia Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 71 Malaysia Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 72 Malaysia Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 73 Malaysia Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 74 Malaysia Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 75 Rest of Asia Pacific Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 76 Rest of Asia Pacific Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 77 Rest of Asia Pacific Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 78 Rest of Asia Pacific Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 79 Rest of Asia Pacific Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 80 Rest of Asia Pacific Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 81 Rest of Asia Pacific Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 82 Rest of Asia Pacific Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 83 Key Information – Biogen, Inc.
TABLE 84 Key Information – Bayer AG
TABLE 85 Key Information – Apellis Pharmaceuticals, Inc.
TABLE 86 Key Information – Regeneron Pharmaceuticals, Inc.
TABLE 87 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 88 Key information – Ionis Pharmaceuticals, Inc.
TABLE 89 Key Information – Novartis AG
TABLE 90 Key Information – Sanofi S.A.
TABLE 91 Key Information – Coherus Biosciences, Inc.
TABLE 92 key information – Bausch Health Companies, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Age Related Macular Degeneration (AMD) Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Age Related Macular Degeneration (AMD)Market
FIG 4 Porter’s Five Forces Analysis – Age Related Macular Degeneration (AMD) Market
FIG 5 Asia Pacific Age Related Macular Degeneration (AMD) Market share by Drug Type, 2022
FIG 6 Asia Pacific Age Related Macular Degeneration (AMD) Market share by Drug Type, 2030
FIG 7 Asia Pacific Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2030, USD Million
FIG 8 Asia Pacific Age Related Macular Degeneration (AMD) Market share by Disease Type, 2022
FIG 9 Asia Pacific Age Related Macular Degeneration (AMD) Market share by Disease Type, 2030
FIG 10 Asia Pacific Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2030, USD Million
FIG 11 Asia Pacific Age Related Macular Degeneration (AMD) Market share by Distribution Channel, 2022
FIG 12 Asia Pacific Age Related Macular Degeneration (AMD) Market share by Distribution Channel, 2030
FIG 13 Asia Pacific Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2030, USD Million
FIG 14 Asia Pacific Age Related Macular Degeneration (AMD) Market share by Country, 2022
FIG 15 Asia Pacific Age Related Macular Degeneration (AMD) Market share by Country, 2030
FIG 16 Asia Pacific Age Related Macular Degeneration (AMD) Market by Country, 2019 - 2030, USD Million
FIG 17 Swot Analysis: Biogen, Inc.
FIG 18 Swot Analysis: Bayer AG
FIG 19 Swot Analysis: Apellis Pharmaceuticals, Inc.
FIG 20 Swot Analysis: Regeneron Pharmaceuticals, Inc.
FIG 21 Swot Analysis: F. Hoffmann-La Roche Ltd.
FIG 22 Swot Analysis: Ionis Pharmaceuticals, Inc.
FIG 23 SWOT Analysis: Novartis AG
FIG 24 Swot Analysis: Sanofi S.A.
FIG 25 Swot Analysis: Coherus Biosciences, Inc.
FIG 26 Swot Analysis: Bausch Health Companies, Inc.
Unique Offerings 